Brian C. Broderick’s Merck MRK Stock Holding History

Brian C. Broderick’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.68M	Buy	22,250 +253	+1%	+$29.2K	0.49%	44
2025 Q4	$2.32M	Hold	21,997	–	–	0.44%	42
2025 Q3	$1.85M	Hold	21,997	–	–	0.35%	48
2025 Q2	$1.74M	Sell	21,997 -150	-0.7%	-$11.9K	0.34%	49
2025 Q1	$1.99M	Hold	22,147	–	–	0.4%	43
2024 Q4	$2.2M	Hold	22,147	–	–	0.43%	42
2024 Q3	$2.52M	Sell	22,147 -55	-0.2%	-$6.53K	0.49%	43
2024 Q2	$2.75M	Buy	22,202 +633	+3%	+$81.5K	0.56%	39
2024 Q1	$2.85M	Buy	21,569 +13,944	+183%	+$1.72M	0.61%	36
2023 Q4	$831K	Buy	7,625 +1,500	+24%	+$156K	0.21%	53
2023 Q3	$631K	Hold	6,125	–	–	0.17%	58
2023 Q2	$707K	Sell	6,125 -25	-0.4%	-$2.84K	0.19%	52
2023 Q1	$654K	Hold	6,150	–	–	0.18%	56
2022 Q4	$682K	Buy	6,150 +500	+9%	+$51.1K	0.2%	54
2022 Q3	$487K	Hold	5,650	–	–	0.15%	57
2022 Q2	$516K	Hold	5,650	–	–	0.16%	58
2022 Q1	$463K	Buy	5,650 +35	+0.6%	+$2.76K	0.12%	60
2021 Q4	$431K	Sell	5,615 -3,468	-38%	-$276K	0.1%	61
2021 Q3	$683K	Sell	9,083 -267	-3%	-$20.3K	0.18%	58
2021 Q2	$727K	Sell	9,350 -554	-6%	-$41.2K	0.19%	55
2021 Q1	$729K	Sell	9,904 -1,152	-10%	-$85K	0.21%	52
2020 Q4	$862K	Sell	11,056 -74	-0.7%	-$5.66K	0.26%	50
2020 Q3	$880K	Sell	11,130 -2,363	-18%	-$185K	0.28%	53
2020 Q2	$996K	Sell	13,493 -472	-3%	-$35.5K	0.33%	55
2020 Q1	$1.03M	Sell	13,965 -183	-1%	-$14.4K	0.41%	52
2019 Q4	$1.23M	Buy	14,148 +1,070	+8%	+$87.9K	0.4%	53
2019 Q3	$1.05M	Sell	13,078 -1,260	-9%	-$101K	0.36%	53
2019 Q2	$1.15M	Sell	14,338 -2,651	-16%	-$203K	0.4%	52
2019 Q1	$1.35M	Sell	16,989 -2,395	-12%	-$179K	0.48%	51
2018 Q4	$1.41M	Sell	19,384 -1,048	-5%	-$74K	0.59%	46
2018 Q3	$1.38M	Sell	20,432 -1,153	-5%	-$73.5K	0.47%	52
2018 Q2	$1.25M	Sell	21,585 -104	-0.5%	-$5.87K	0.46%	52
2018 Q1	$1.13M	Sell	21,689 -428	-2%	-$23.1K	0.42%	54
2017 Q4	$1.19M	Sell	22,117 -15,552	-41%	-$862K	0.43%	53
2017 Q3	$2.3M	Sell	37,669 -5,813	-13%	-$352K	0.83%	42
2017 Q2	$2.66M	Sell	43,482 -2,283	-5%	-$139K	0.98%	35
2017 Q1	$2.77M	Sell	45,765 -1,236	-3%	-$75K	1.13%	33
2016 Q4	$2.64M	Sell	47,001 -670	-1%	-$39.2K	1.14%	31
2016 Q3	$2.84M	Sell	47,671 -2,830	-6%	-$165K	1.21%	30
2016 Q2	$2.78M	Sell	50,501 -1,184	-2%	-$63K	1.17%	28
2016 Q1	$2.61M	Buy	51,685 +4,821	+10%	+$236K	1.13%	31
2015 Q4	$2.36M	Buy	46,864 +13,519	+41%	+$682K	1.06%	33
2015 Q3	$1.57M	Sell	33,345 -257	-0.8%	-$13.7K	0.73%	51
2015 Q2	$1.83M	Sell	33,602 -388	-1%	-$21.8K	0.78%	46
2015 Q1	$1.86M	Buy	33,990 +299	+0.9%	+$16.9K	0.77%	46
2014 Q4	$1.82M	Buy	33,691 +792	+2%	+$44.1K	0.77%	46
2014 Q3	$1.86M	Sell	32,899 -656	-2%	-$36.8K	0.83%	44
2014 Q2	$1.85M	Sell	33,555 -354	-1%	-$19.3K	0.85%	41
2014 Q1	$1.84M	Sell	33,909 -419	-1%	-$21.7K	0.9%	39
2013 Q4	$1.64M	Sell	34,328 -1,048	-3%	-$47.9K	0.82%	40
2013 Q3	$1.61M	Sell	35,376 -524	-1%	-$23.9K	0.9%	36
2013 Q2	$1.59M	Buy	+35,900	New	+$1.6M	0.95%	34

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Brian C. Broderick's MRK Position: Q1 2026 in Review

Brian C. Broderick increased its Merck (MRK) stake by 1.2% in Q1 2026, buying an estimated $29.2K and bringing the position to 22,250 shares worth $2.68M. The position accounts for 0.49% of the portfolio, ranked #44.

Brian C. Broderick first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.85M in Q1 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Brian C. Broderick held 22,250 shares of Merck worth $2.68M as of Q1 2026.
Brian C. Broderick bought 253 Merck shares in Q1 2026, an estimated $29.2K.
Merck made up 0.49% of Brian C. Broderick's portfolio in Q1 2026, its #44 holding.
Brian C. Broderick first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
Brian C. Broderick's Merck position peaked at $2.85M in Q1 2024.
3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Brian C. Broderick's 13F filing for Q1 2026, filed 7 May 2026.